407 related articles for article (PubMed ID: 15017051)
1. Design and expression of chimeric U1/ribozyme transgenes.
Abounader R; Montgomery R; Dietz H; Laterra J
Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of HCV replication by HCV specific U1 small nuclear RNA chimeric ribozyme in vivo].
Wang MX; Jin QL; Pan Y; Wang F; Niu JQ
Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):11-4. PubMed ID: 16420757
[TBL] [Abstract][Full Text] [Related]
3. [Study on the cleavage activity of U1 small nuclear RNA chimeric ribozyme against HCV RNA in vitro].
Tian MM; Wang F; Niu JQ; Wang MX
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):749-51. PubMed ID: 15619345
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
[TBL] [Abstract][Full Text] [Related]
5. [The cleavage activity of GCV transfer vector-mediated hammerhead ribozyme for KRR1 in vitro transcript].
Chen LF; Li JH; Zou YX; Zhao YP; Cao LL; Zhang XC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):279-84. PubMed ID: 18038796
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
[TBL] [Abstract][Full Text] [Related]
7. Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats.
Song YH; Chen XL; Kong XJ; Liu NZ; Li W; Wu XL; Lin JS; Jin YX
J Gene Med; 2005 Jul; 7(7):965-76. PubMed ID: 15772939
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
Nash KL; Alexander GJ; Lever AM
J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
[TBL] [Abstract][Full Text] [Related]
9. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
Kronenwett R; Haas R; Sczakiel G
J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
[TBL] [Abstract][Full Text] [Related]
10. Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus.
Hoeprich S; Zhou Q; Guo S; Shu D; Qi G; Wang Y; Guo P
Gene Ther; 2003 Aug; 10(15):1258-67. PubMed ID: 12858191
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
12. U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre-mRNA of human immunodeficiency virus.
Michienzi A; Prislei S; Bozzoni I
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7219-24. PubMed ID: 8692972
[TBL] [Abstract][Full Text] [Related]
13. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
Tang J; Breaker RR
RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
[TBL] [Abstract][Full Text] [Related]
14. [Clone, expression and cleavage activity of anti-caspase-7 hammerhead ribozyme in vitro].
Zhang W; Xie Q; Zhou XQ; Jiang S; Jin YX
Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):684-7. PubMed ID: 15623380
[TBL] [Abstract][Full Text] [Related]
15. A novel chimeric ribozyme vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium.
Sonnenday CJ; Warren DS; Cooke SK; Dietz HC; Montgomery RA
J Gene Med; 2004 Dec; 6(12):1394-402. PubMed ID: 15538724
[TBL] [Abstract][Full Text] [Related]
16. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
[TBL] [Abstract][Full Text] [Related]
18. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
19. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
Sullivan JM; Pietras KM; Shin BJ; Misasi JN
Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
[TBL] [Abstract][Full Text] [Related]
20. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
